Search Legislation

The National Health Service (General Medical Services) (Scotland) Amendment (No. 3) Regulations 2003

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of Schedule 1 to the principal Regulations

3.  In Schedule 1 to the principal Regulations (terms of service for doctors)–

(a)in paragraph 1–

(i)after sub-paragraph (a) insert–

(aa)“independent nurse prescriber” means–

(i)a person whose name is registered–

(aaA)in Part 1 or 12 of the nurses' and midwives' professional register and has a district nurse qualification additionally recorded in the nurses' and midwives' professional register pursuant to rule 11 of the Nurses, Midwives and Health Visitors Rules 1983(1); or

(bbB)in Part 11 of the nurses' and midwives' professional register as a health visitor,

and against whose name is recorded in the nurses' and midwives' professional register an annotation signifying that he is qualified to order drugs, medicines and appliances from the Nurse Prescribers' Formulary for Community Nurses and Health Visitors in Part 8B of the Drug Tariff(2); or

(ii)a person–

(aaA)whose name is registered in parts 1, 3, 5, 8, 10, 11, 12, 13, 14 or 15 of the nurses' and midwives' professional register; and

(bbB)against whose name is recorded in the nurses' and midwives' professional register an annotation signifying that he is qualified to order drugs, medicines and appliances from the Nurse Prescribers' Extended Formulary in Part 8C of the Drug Tariff;

(ab)“licensing authority” shall be construed in accordance with section 6(3) of the Medicines Act 1968(3);

(ac)“nurses' and midwives' professional register” means the register maintained by the Nursing and Midwifery Council pursuant to paragraph 10 of Schedule 2 to the Nursing and Midwifery Order 2001(4);;

(ii)after paragraph (b) insert–

(ba)“the POM Order” means the Prescription Only Medicines (Human Use) Order 1997(5);;

(iii)in paragraph (d) for “a nurse prescriber” substitute “a supplementary prescriber or an independent nurse prescriber”;

(iv)number the definition of “restricted availability appliance”(6) as paragraph (db);

(v)after paragraph (d) insert–

(da)“prescription only medicine” means a medicine referred to in article 3 of the POM Order (medicinal products on prescription only);;

(vi)after paragraph (db) insert–

(dc)“supplementary prescriber” means a person whose name is registered in–

(i)Parts 1, 3, 5, 8, 10, 11, 12, 13, 14, or 15 of the nurses' and midwives' professional register;

(ii)the Register of Pharmaceutical Chemists maintained in pursuance of section 2(1) of the Pharmacy Act 1954(7); or

(iii)the register maintained in pursuance of articles 6 and 9 of the Pharmacy (Northern Ireland) Order 1976(8),

and against whose name is recorded in the relevant register an annotation signifying that he is qualified to order drugs, medicines and appliances as a supplementary prescriber;;

(b)In paragraph 29A(1) and (2)(9) for the words “a nurse prescriber”, at each place where they occur, substitute “a supplementary prescriber or an independent nurse prescriber”.

(c)In paragraph 29B(1)(10) for the words “a nurse prescriber” substitute “a supplementary prescriber or an independent nurse prescriber”.

(d)After paragraph 29B, insert–

29C.(1) Where, after 10th October 2003, a doctor employs a supplementary prescriber and that person’s functions include prescribing, the doctor shall have arrangements in place to secure that that person will only–

(a)give a prescription for a prescription only medicine;

(b)administer a prescription only medicine for parenteral administration; or

(c)give directions for the administration of a prescription only medicine for parenteral administration,

as a supplementary prescriber under the conditions set out in sub-paragraph (2).

(2) The conditions referred to in sub-paragraph (1) are that–

(a)the person satisfies the applicable conditions set out in article 3B(3)(11) of the POM Order (prescribing and administration by supplementary prescribers), unless those conditions do not apply by virtue of any of the exemptions set out in the subsequent provisions of that Order;

(b)the medicine is not a controlled drug within the meaning of the Misuse of Drugs Act 1971(12);

(c)the medicine is not specified in Schedule 10 (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services);

(d)the medicine is not specified in an entry in column 1 of Schedule 11 (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances), unless–

(i)the patient is a person of a description mentioned in column 2 of that entry;

(ii)the medicine is prescribed for that patient only for the purposes specified in column 3 of that entry; and

(iii)if he is giving a prescription, he endorses the face of the form with the reference “SLS”.

(3) Where, after 10th October 2003, a doctor employs a supplementary prescriber and that person’s functions include prescribing, the doctor shall have arrangements in place to secure that that person will only give a prescription for–

(a)an appliance; or

(b)a medicine which is not a prescription only medicine,

as a supplementary prescriber under the conditions set out in sub-paragraph (4).

(4) The conditions referred to in sub-paragraph (3) are that–

(a)he acts in accordance with a clinical management plan (which may be amended from time to time) which is in effect at the time he acts, which has been agreed by the patient to whom the plan relates, the doctor or dentist who is party to the plan and any supplementary prescriber who is to prescribe, give directions for administration or administer under the plan, and which contains the following particulars:–

(i)the name of the patient to whom the plan relates;

(ii)the illness or conditions which may be treated by the supplementary prescriber;

(iii)the date on which the plan is to take effect, and when it is to be reviewed by the doctor or dentist who is a party to the plan;

(iv)reference to the class or description of medicines or types of appliances which may be prescribed or administered under the plan;

(v)any restrictions or limitations as to the strength or dose of any medicine which may be prescribed or administered under the plan, and any period of administration or use of any medicine or appliance which may be prescribed or administered under the plan;

(vi)relevant warnings about known sensitivities of the patient to, or known difficulties of the patient with, particular medicines or appliances;

(vii)the arrangements for notification of–

(aa)suspected or known adverse reactions to any medicine which may be prescribed or administered under the plan, and suspected or known adverse reactions to any other medicine taken at the same time as any medicine prescribed or administered under the plan; and

(bb)incidents occurring with the appliance which might lead, might have led or has led to the death or serious deterioration of state of health of the patient; and

(viii)the circumstances in which the supplementary prescriber should refer to, or seek the advice of, the doctor or dentist who is a party to the plan;

(b)he has access to the health records of the patient to whom the plan relates which are used by any doctor or dentist who is a party to the plan;

(c)if it is a prescription for a medicine, the medicine is not a controlled drug within the meaning of the Misuse of Drugs Act 1971;

(d)if it is a prescription for a medicine, the medicine is not specified in Schedule 10 (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services);

(e)if it is a prescription for a medicine, the medicine is not specified in an entry in column 1 of Schedule 11 (drugs to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services only in certain circumstances), unless–

(i)the patient is a person of a description mentioned in column 2 of that entry;

(ii)the medicine is prescribed for that patient only for the purposes specified in column 3 of that entry; and

(iii)if he is giving a prescription, he endorses the face of the form with the reference “SLS”;

(f)if it is a prescription for a medicine–

(i)the medicine is the subject of a product licence, a marketing authorisation or a homeopathic certificate of registration granted by the licensing authority or the European Commission; or

(ii)the use of the medicine is for the purposes of a clinical trial, and–

(aa)that trial is the subject of a clinical trial certificate issued in accordance with the Medicines Act 1968(13); or

(bb)a clinical trial certificate is not needed in respect of that trial by virtue of any exemption conferred by or under that Act;

(g)if it is a prescription for an appliance, the appliance is listed in the Drug Tariff; and

(h)if it is a prescription for a restricted availability appliance–

(i)the patient is a person of a description mentioned in the entry in the Drug Tariff in respect of that appliance;

(ii)the appliance is prescribed only for the purposes specified in respect of that person in that entry; and

(iii)when giving the prescription, he endorses the face of the form with the reference “SLS”..

(1)

Approved by S.I. 1983/873 and set out in the Schedule thereto; there are no relevant amending instruments.

(2)

Copies of the Drug Tariff are available for inspection at the offices of Health Boards and primary care NHS trusts in accordance with S.I. 1995/414 as amended by S.S.I. 1999/57.

(4)

S.I. 2002/253.

(5)

S.I. 1997/1830; the relevant amending instruments are S.I. 2002/549 and 2003/696.

(6)

The definition of “restricted availability appliance” was inserted by S.S.I. 2002/111.

(8)

S.I. 1976/1213.

(9)

Paragraph 29A was inserted by S.I. 1996/1504.

(10)

Paragraph 29B was inserted by S.I. 1999/1620 and amended by S.S.I. 1999/54.

(11)

Article 3B was inserted by S.I. 2003/696.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources